Ocular Therapeutix Statistics
Total Valuation
OCUL has a market cap or net worth of $2.23 billion. The enterprise value is $1.71 billion.
| Market Cap | 2.23B |
| Enterprise Value | 1.71B |
Important Dates
The next estimated earnings date is Tuesday, November 3, 2026, before market open.
| Earnings Date | Nov 3, 2026 |
| Ex-Dividend Date | n/a |
Share Statistics
OCUL has 219.62 million shares outstanding. The number of shares has increased by 26.40% in one year.
| Current Share Class | 219.62M |
| Shares Outstanding | 219.62M |
| Shares Change (YoY) | +26.40% |
| Shares Change (QoQ) | +0.38% |
| Owned by Insiders (%) | 1.20% |
| Owned by Institutions (%) | 79.98% |
| Float | 184.76M |
Valuation Ratios
| PE Ratio | n/a |
| Forward PE | n/a |
| PS Ratio | 43.20 |
| Forward PS | 39.38 |
| PB Ratio | 4.53 |
| P/TBV Ratio | 4.32 |
| P/FCF Ratio | n/a |
| P/OCF Ratio | n/a |
| PEG Ratio | n/a |
Enterprise Valuation
| EV / Earnings | n/a |
| EV / Sales | 33.23 |
| EV / EBITDA | n/a |
| EV / EBIT | n/a |
| EV / FCF | n/a |
Financial Position
The company has a current ratio of 13.11, with a Debt / Equity ratio of 0.15.
| Current Ratio | 13.11 |
| Quick Ratio | 12.79 |
| Debt / Equity | 0.15 |
| Debt / EBITDA | n/a |
| Debt / FCF | n/a |
| Interest Coverage | -27.53 |
Financial Efficiency
Return on equity (ROE) is -72.99% and return on invested capital (ROIC) is -39.95%.
| Return on Equity (ROE) | -72.99% |
| Return on Assets (ROA) | -34.95% |
| Return on Invested Capital (ROIC) | -39.95% |
| Return on Capital Employed (ROCE) | -50.46% |
| Weighted Average Cost of Capital (WACC) | 9.63% |
| Revenue Per Employee | $160,169 |
| Profits Per Employee | -$927,529 |
| Employee Count | 325 |
| Asset Turnover | 0.09 |
| Inventory Turnover | 67.07 |
Taxes
| Income Tax | n/a |
| Effective Tax Rate | n/a |
Stock Price Statistics
The stock price has decreased by -19.24% in the last 52 weeks. The beta is 0.97, so OCUL's price volatility has been similar to the market average.
| Beta (5Y) | 0.97 |
| 52-Week Price Change | -19.24% |
| 50-Day Moving Average | 9.89 |
| 200-Day Moving Average | 9.91 |
| Relative Strength Index (RSI) | 48.58 |
| Average Volume (20 Days) | 2,201,143 |
Short Selling Information
The latest short interest is 28.06 million, so 12.77% of the outstanding shares have been sold short.
| Short Interest | 28.06M |
| Short Previous Month | 28.52M |
| Short % of Shares Out | 12.77% |
| Short % of Float | 15.18% |
| Short Ratio (days to cover) | 10.28 |
Income Statement
In the last 12 months, OCUL had revenue of $52.06 million and -$301.45 million in losses. Loss per share was -$1.41.
| Revenue | 52.06M |
| Gross Profit | -178.16M |
| Operating Income | -313.91M |
| Pretax Income | -301.45M |
| Net Income | -301.45M |
| EBITDA | -308.46M |
| EBIT | -313.91M |
| Loss Per Share | -$1.41 |
Balance Sheet
The company has $598.64 million in cash and $79.38 million in debt, with a net cash position of $519.26 million or $2.36 per share.
| Cash & Cash Equivalents | 598.64M |
| Total Debt | 79.38M |
| Net Cash | 519.26M |
| Net Cash Per Share | $2.36 |
| Equity (Book Value) | 520.04M |
| Book Value Per Share | 2.37 |
| Working Capital | 595.25M |
Cash Flow
In the last 12 months, operating cash flow was -$238.24 million and capital expenditures -$16.86 million, giving a free cash flow of -$255.10 million.
| Operating Cash Flow | -238.24M |
| Capital Expenditures | -16.86M |
| Depreciation & Amortization | 5.45M |
| Net Borrowing | n/a |
| Free Cash Flow | -255.10M |
| FCF Per Share | -$1.16 |
Margins
| Gross Margin | n/a |
| Operating Margin | -603.03% |
| Pretax Margin | -579.09% |
| Profit Margin | n/a |
| EBITDA Margin | n/a |
| EBIT Margin | n/a |
| FCF Margin | n/a |
Dividends & Yields
OCUL does not appear to pay any dividends at this time.
| Dividend Per Share | n/a |
| Dividend Yield | n/a |
| Dividend Growth (YoY) | n/a |
| Years of Dividend Growth | n/a |
| Payout Ratio | n/a |
| Buyback Yield | -26.40% |
| Shareholder Yield | -26.40% |
| Earnings Yield | -13.40% |
| FCF Yield | -11.34% |
Analyst Forecast
The average price target for OCUL is $27.09, which is 167.16% higher than the current price. The consensus rating is "Strong Buy".
| Price Target | $27.09 |
| Price Target Difference | 167.16% |
| Analyst Consensus | Strong Buy |
| Analyst Count | 11 |
| Revenue Growth Forecast (3Y) | 76.74% |
| EPS Growth Forecast (3Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | n/a |
| Lynch Upside | n/a |
| Graham Number | n/a |
| Graham Upside | n/a |
Stock Splits
This stock does not have any record of stock splits.
| Last Split Date | n/a |
| Split Type | n/a |
| Split Ratio | n/a |
Scores
OCUL has an Altman Z-Score of 5.42 and a Piotroski F-Score of 2.
| Altman Z-Score | 5.42 |
| Piotroski F-Score | 2 |